Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Zolot, Joan PA

Abstract

According to this study:

 

* Intraperitoneal chemotherapy used in combination with iv chemotherapy increased three-year survival rates in women with stage III ovarian cancer, compared with iv chemotherapy alone.

 

* But those receiving intraperitoneal and iv chemotherapy were more likely to need changes to their treatment regimen because of treatment-related toxicities than those receiving only iv chemotherapy.

 

* Although the use of intraperi-toneal and iv chemotherapy together has increased over the past decade, fewer than half of eligible patients receive it.